What is the Future of High Throughput Screening in Cancer Research?
The future of HTS in cancer research looks promising with ongoing advancements in technology and methodology. The integration of multi-omics approaches (e.g., genomics, proteomics, metabolomics) with HTS is expected to provide a more comprehensive understanding of cancer biology. Additionally, the development of more sophisticated bioinformatics tools will help in managing and interpreting the large datasets generated by HTS. Ultimately, these advancements aim to accelerate the discovery of new cancer therapies and improve patient outcomes.
